Literature DB >> 25445171

Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.

Feng Wang1, Chen Chen, Daowen Wang.   

Abstract

microRNAs (miRNAs) are a class of conserved, short, non-coding RNAs that have important and potent capacities to regulate gene expression at the posttranscriptional level. In the past several years, the aberrant expressions of miRNAs in the cardiovascular system have been widely reported, and the crucial roles of some special miRNAs in heart development and pathophysiology of various cardiovascular diseases have been gradually recognized. Recently, it was discovered that miRNAs are presented in peripheral circulation abundantly and stably. This has raised the possibility of using circulating miRNAs as biomarkers for diseases. Furthermore, some studies demonstrated that circulating miRNAs may serve as novel extracellular communicators of cell-cell communication. These discoveries not only reveal the functions of circulating miRNAs in cardiovascular system but also inform the development of miRNAs therapeutic strategies. In this review, we discuss the potential roles of circulating miRNAs in a variety of cardiovascular diseases from biomarkers to therapeutic targets to clearly understand the roles of circulating miRNAs in cardiovascular system.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25445171     DOI: 10.1007/s11684-014-0379-2

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  116 in total

Review 1.  Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?

Authors:  Stephan Fichtlscherer; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

2.  MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction.

Authors:  Emanuela Bostjancic; Nina Zidar; Dusan Stajer; Damjan Glavac
Journal:  Cardiology       Date:  2009-12-21       Impact factor: 1.869

3.  Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure.

Authors:  Rusty L Montgomery; Thomas G Hullinger; Hillary M Semus; Brent A Dickinson; Anita G Seto; Joshua M Lynch; Christianna Stack; Paul A Latimer; Eric N Olson; Eva van Rooij
Journal:  Circulation       Date:  2011-09-06       Impact factor: 29.690

4.  Secreted monocytic miR-150 enhances targeted endothelial cell migration.

Authors:  Yujing Zhang; Danqing Liu; Xi Chen; Jing Li; Limin Li; Zhen Bian; Fei Sun; Jiuwei Lu; Yuan Yin; Xing Cai; Qi Sun; Kehui Wang; Yi Ba; Qiang Wang; Dongjin Wang; Junwei Yang; Pingsheng Liu; Tao Xu; Qiao Yan; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

Review 5.  MicroRNAs and cardiovascular diseases.

Authors:  Koh Ono; Yasuhide Kuwabara; Jiahuai Han
Journal:  FEBS J       Date:  2011-03-30       Impact factor: 5.542

6.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

Review 7.  Circulating microRNAs as potential non-invasive biomarkers for the early detection of hypertension-related stroke.

Authors:  W Y Li; J Jin; J Chen; Y Guo; J Tang; S Tan
Journal:  J Hum Hypertens       Date:  2013-10-17       Impact factor: 3.012

8.  Proteomic analysis of secretory proteins and vesicles in vascular research.

Authors:  Giordano Pula; Sue Perera; Marianna Prokopi; Anissa Sidibe; Chantal M Boulanger; Manuel Mayr
Journal:  Proteomics Clin Appl       Date:  2008-06       Impact factor: 3.494

9.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

10.  Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans.

Authors:  Guangwen Long; Feng Wang; Huaping Li; Zhongwei Yin; Chaugai Sandip; Yan Lou; Yan Wang; Chen Chen; Dao Wen Wang
Journal:  BMC Neurol       Date:  2013-11-16       Impact factor: 2.474

View more
  18 in total

Review 1.  miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation.

Authors:  Xiao-Min Xu; Hong-Jie Zhang
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

2.  Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21.

Authors:  Muayad Albadrani; Ratanesh K Seth; Sutapa Sarkar; Diana Kimono; Ayan Mondal; Dipro Bose; Dwayne E Porter; Geoff I Scott; Bryan Brooks; Samir Raychoudhury; Mitzi Nagarkatti; Prakash Nagarkatti; Yvon Jule; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-08-08       Impact factor: 4.052

Review 3.  Urinary microRNA in kidney disease: utility and roles.

Authors:  In O Sun; Lilach O Lerman
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-13

4.  miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes.

Authors:  Giuliana Ventriglia; Francesca Mancarella; Guido Sebastiani; Dana P Cook; Roberto Mallone; Chantal Mathieu; Conny Gysemans; Francesco Dotta
Journal:  Diabetologia       Date:  2019-10-28       Impact factor: 10.122

5.  Emerging roles of microRNAs in the regulation of Toll-like receptor (TLR)-signaling.

Authors:  Saswati Banerjee; Winston E Thompson; Indrajit Chowdhury
Journal:  Front Biosci (Landmark Ed)       Date:  2021-01-01

Review 6.  MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown.

Authors:  Maria Braoudaki; George I Lambrou
Journal:  J Hematol Oncol       Date:  2015-02-06       Impact factor: 17.388

7.  Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis.

Authors:  Suxia Bao; Jianming Zheng; Ning Li; Chong Huang; Mingquan Chen; Qi Cheng; Kangkang Yu; Shengshen Chen; Mengqi Zhu; Guangfeng Shi
Journal:  Gut Liver       Date:  2017-11-15       Impact factor: 4.519

8.  Effects of Rosuvastatin and MiR-126 on Myocardial Injury Induced by Acute Myocardial Infarction in Rats: Role of Vascular Endothelial Growth Factor A (VEGF-A).

Authors:  Ling Fei; Jun Zhang; Heping Niu; Chen Yuan; Xiaoli Ma
Journal:  Med Sci Monit       Date:  2016-07-04

9.  Dysregulated miRNAs and their pathogenic implications for the neurometabolic disease propionic acidemia.

Authors:  Ana Rivera-Barahona; Alejandro Fulgencio-Covián; Celia Pérez-Cerdá; Ricardo Ramos; Michael A Barry; Magdalena Ugarte; Belén Pérez; Eva Richard; Lourdes R Desviat
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

10.  Dysregulation of microRNAs and renin-angiotensin system in high salt diet-induced cardiac dysfunction in uninephrectomized rats.

Authors:  Venkateswara Rao Amara; Sunil Kumar Surapaneni; Kulbhushan Tikoo
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.